« Back to Record
Citation APA

Van Meerhaeghe, T., Baurain, J.-F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., & Aspeslagh, S. (2022). Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients (Néphrologie & Thérapeutique, (2022), 18, 5, (372), 10.1016/j.nephro.2022.07.395). Nephrology frontier, 2, 1129134. doi:10.3389/fneph.2022.1129134


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/386469

Van Meerhaeghe, T., Baurain, J.-F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., & Aspeslagh, S. (2022). Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients (Néphrologie & Thérapeutique, (2022), 18, 5, (372), 10.1016/j.nephro.2022.07.395). Nephrology frontier, 2, 1129134. doi:10.3389/fneph.2022.1129134